# Chongqing Southwest No 2 Pharmaceutical Factory Co., Ltd – FDA Inspection, Apr 28, 2017

Source: https://www.keypedia.com/records/fda_inspections/chongqing-southwest-no-2-pharmaceutical-factory-co-ltd/4330cf6e-8453-4f85-b122-5f6257657210
Source feed: FDA_Inspections

> FDA inspection 1021732 of Chongqing Southwest No 2 Pharmaceutical Factory Co., Ltd, April 28, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1021732
- Company Name: Chongqing Southwest No 2 Pharmaceutical Factory Co., Ltd
- Inspection Date: 2017-04-28
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1243715 - 2024-05-31](https://www.keypedia.com/records/fda_inspections/chongqing-southwest-no-2-pharmaceutical-factory-co-ltd/4beff8dd-a276-4a7c-9e73-48ca404cefee)
- FDA Inspection 985510 - 2016-07-28
- FDA Inspection 794375 - 2012-07-19

## Related Officers

- [Teresa I. Navas](https://www.keypedia.com/people/teresa-i-navas/43f747c0-18c2-4630-bab9-936204aa93aa)

Company: https://www.keypedia.com/companies/chongqing-southwest-no-2-pharmaceutical-factory-co-ltd/dbcf7c68-8b86-427d-90cd-92c27afcb7fa

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
